Database Provides Details of India's In Vitro Diagnostics Segment

A new India database provides details of unit installation of diagnostics analyzers, volume consumption of reagents and test assays, and the penetration of key in vitro diagnostics (IVD) brands by city, model, and user segment.

The improved database showed more technology adoptions and higher-end automated equipment purchases in large lab facilities especially in the Southern and Western regions of India. There are nearly 1800 automated systems in clinical chemistry across India, which represents only 12-15% of total analyzers installed but nearly 50% of the total revenue, valued at approximately US$ 35-40 million in 2007. Trends observed in the database also revealed that local players are gaining stronger market presence, with Transasia (Mumbai, India) extending its market leadership specifically in clinical chemistry and hematology.

Transasia's Erba Chem Series and Bayer's (Berlin, Germany) small random access (RA) systems are the most common clinical chemistry (CC) analyzers in all types of facilities. These analyzers act as back-up instruments in larger lab facilities. Bayer is pushing more of its Advia systems and has seen an increase in installations in recent years while old systems are being phased out.

Clearstate's (Singapore) IVD Gateway Database in India provides insights into instrument installation and test consumption trends by tracking market changes and usage patterns quarterly. The Gateway database is a unique healthcare service by Clearstate, a niche healthcare consultancy, developed to provide accurate and comprehensive information on medical device usage and demand across Asia Pacific. Clearstate provides actual and up-to-date placement, usage, and consumption data for devices, equipment, and consumables found in healthcare and commercial settings.


Related Links:
Transasia
Bayer
Clearstate